EUVIMEDEUVIMED entdecken
Leserbrief

Treatment Escalation and Risk Factors for Intrapleural Enzymatic Therapy Failure

Leela Krishna Teja Boppana, Hiren J Mehta

CHEST · 2026-06 · 169 (6) · e200-e201

DOI: 10.1016/j.chest.2026.01.010 ↗

Kurz gefasst

Leserbrief in der Zeitschrift CHEST, 2026-06. Verfasst von Leela Krishna Teja Boppana und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Rochester Medical Center, Rochester, NY. Electronic address: lktboppana@gmail.com. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • University of Rochester Medical Center, Rochester, NY. Electronic address: lktboppana@gmail.com.
  • Division of Pulmonary, Critical Care and Sleep Medicine, University of Florida Health, Gainesville, FL.

Zitieren

APA

Boppana, L. K. T., & Mehta, H. J. (2026). Treatment Escalation and Risk Factors for Intrapleural Enzymatic Therapy Failure. CHEST, 169(6), e200-e201. https://doi.org/10.1016/j.chest.2026.01.010

Vancouver

Boppana LKT, Mehta HJ. Treatment Escalation and Risk Factors for Intrapleural Enzymatic Therapy Failure. CHEST. 2026;169(6):e200-e201. doi:10.1016/j.chest.2026.01.010

BibTeX
@article{Boppana2026,
  author = {Boppana, Leela Krishna Teja and Mehta, Hiren J},
  title = {Treatment Escalation and Risk Factors for Intrapleural Enzymatic Therapy Failure},
  journal = {CHEST},
  year = {2026},
  volume = {169},
  number = {6},
  pages = {e200--e201},
  doi = {10.1016/j.chest.2026.01.010}
}
Kostenlos starten →